Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.40 (0.62%)
Bid:
65.20
Ask:
65.50
Spread: 0.30 (0.46%)
Market Cap: £577.76m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Form 8.5 (EPT/RI) - IP Group plc

Today 11:19

RNS Number : 4131J
Bank of America Merrill Lynch
23 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Name of exempt principal trader:

Merrill Lynch International

(b)

Name of offeror/offeree in relation to whoserelevant securities this form relates: Use a separate form for each offeror/offeree

IP Group PLC

(c)

Name of the party to the offer with which exempt principal trader is connected:

IP Group PLC

(d)

Date dealing undertaken:

22/06/2026

(e)

In addition to the company in 1(b) above, is theexempt principal trader making disclosures inrespect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.

DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional classof relevant security dealt in.The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

Class of relevant security

Purchases/sales

Total number of securities

Highest price per unitpaid/received

Lowest price per unitpaid/received

Common Stock

Purchase

773,425

0.687967 GBP

0.631899 GBP

Common Stock

Sale

960,094

0.687967 GBP

0.629000 GBP

 

(b)

Cash-settled derivative transactions

Class of relevant security

Product descriptione.g. CFD

Nature of dealinge.g. opening/closing a long/short position, increasing/reducing along/short position

Number of reference securities

Price per unit

Common Stock

Swaps - Equity Swaps

Increasing a Long Position

26,718

0.670733 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Long Position

26,718

0.650000 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

7,724

0.650000 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

7,724

0.650000 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Long Position

2,086

0.631500 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Long Position

2,779

0.631500 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Long Position

2,086

0.631500 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Long Position

2,779

0.631500 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

16,200

0.659983 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

788

0.656388 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

61

0.635940 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

2,064

0.656388 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

93

0.656388 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

5,797

0.656388 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Long Position

6,717

0.665092 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Long Position

7

0.660013 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

1,895

0.641505 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

26,718

0.650000 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

7,724

0.650000 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

124,196

0.649586 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

788

0.649730 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

3

0.633000 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Long Position

9

0.668734 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Long Position

11

0.649935 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

1,078

0.633548 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

7,945

0.633850 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

1,078

0.633850 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

1,415

0.632137 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

586

0.633549 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

4,903

0.633850 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

847

0.632120 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Long Position

6,887

0.644297 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

12,169

0.639170 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

5,359

0.677876 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

12,366

0.677876 GBP

Common Stock

Swaps - Equity Swaps

Opening a Short Position

452,834

0.661834 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

452,834

0.658941 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

172,422

0.670733 GBP

Common Stock

Swaps - Equity Swaps

Reducing a Short Position

547

0.670733 GBP

Common Stock

Swaps - Equity Swaps

Increasing a Short Position

172,422

0.647830 GBP

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class ofrelevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number ofsecurities to which option relates

Exercise priceper unit

Typee.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)

Exercise

Class of relevant security

Product descriptione.g. call option

Exercising/exercisedagainst

Number of securities

Exercise Price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.

OTHER INFORMATION

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or(ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

23/06/2026

Contact name:

Kamil Dziedzic

Telephone number:

+353 86 168 4821

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService.The Panel's Market Surveillance Unit is available for consultation in relation to the Code'sdealing disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERAKNBDKBKDCAB
Date   Source Headline
23rd Jun 202611:22 amRNSForm 8.5 (EPT/NON-RI) - IP Group plc
23rd Jun 202611:19 amRNSForm 8.5 (EPT/RI) - IP Group plc
23rd Jun 20269:49 amRNSForm 8.5 (EPT/RI) - IP Group PLC
22nd Jun 20264:27 pmRNSDisclosure Table
22nd Jun 20264:06 pmRNSStatement re Possible Offer
18th Jun 20261:54 pmRNSResult of AGM
16th Jun 20267:00 amRNS-RIstesso starts trial of leramistat in sarcopenia
11th Jun 20267:00 amRNSHolding(s) in Company
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.